Table 4.

Correlates associated with discontinuing endocrine therapy or nonadherence

ReasonStudy
Side effectsDemissie et al. (55), Kahn et al. (56), Lash et al. (57), Cluze et al. (65)
Higher comorbidityHershman et al. (23), Hadji (26), Sedjo and Devine (62)
Financial considerations or low socioeconomic statusKimmeck et al. (85), Riley et al. (60), Neugut et al. (61), Liu et al. (66)
Very young or older ageHershman et al. (23), Land et al. (50), Owusu et al. (58)
Lack of physician recommendationDavidson et al. (41)
Perception of low risk of recurrenceFink et al. (54)
Lack of social supportCluze et al. (86), Land et al. (50)
Follow-up care with general practitioner vs. oncologistMurphy et al. (21)
African American race/ethnicityHershman et al. (23)
Cigarette smokingLand et al. (50)
Presence of anxiety/depression linked to better adherenceKyvernitakis et al. (71), Hadji (26)
Alcohol useLand et al. (50)